Zanamivir
Zanamivir is a substance that is being studied in the treatment of prostate cancer.
Class[edit | edit source]
It belongs to the family of drugs called endothelin-receptor antagonists.
Information about Zanamivir[edit source]
- Zanamivir is an inhibitor of the influenza neuramidase enzyme and is given by inhalation as therapy and prophylaxis against influenza A and B.
- Zanamivir may be used to treat and prevent infections from influenza A (H1N1).
Liver safety of Zanamivir[edit source]
Zanamivir has not been associated with clinically apparent liver injury, at least when given by inhalation.
Mechanism of action of Zanamivir[edit source]
- Zanamivir (za nam' i vir) is a sialic acid analogue and a potent inhibitor of the neuraminidase of influenza viruses.
- Inhibition of this enzyme causes a decrease in viral replication, probably as a result of interference with particle formation and release. Zanamivir is active against both influenza A and B viruses, but has no activity against other common upper respiratory tract viruses.
- In addition, resistance to zanamivir can develop rapidly.
- Zanamivir is indicated for therapy or post-exposure prevention of influenza A or B.
FDA approval information for Zanamivir[edit source]
- Zanamivir was approved in the United States in 1999 and is frequently used during influenza outbreaks.
- Zanamivir is available as a powder for inhalation (5 mg/blister pack) under the brand name of Relenza.
Dose[edit | edit source]
- The recommended dose for therapy in adults is 2 oral inhalations of 5 mg each, twice daily for 5 days;
- the usual prophylactic regimen is 10 mg once daily for 10 days, starting within 2 days of close contact with an infected person or for 28 days in a community setting.
Side effects of Zanamivir[edit source]
Side effects are uncommon and include mild nausea, dizziness, headache, cough, nasal and throat irritation and bronchospasm.
More serious side effects[edit | edit source]
- difficulty breathing
- wheezing
- shortness of breath
- hives
- rash
- itching
- difficulty swallowing
- swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
- hoarseness
Brand names[edit | edit source]
Relenza®
Step by step instructions[edit | edit source]
Cost[edit | edit source]
- The lowest GoodRx price for the most common version of Relenza is around $69.40, 9% off the average retail price of $76.28.
External links[edit | edit source]
- Relenza: Consumer Questions and Answers US Food and Drug Administration (FDA)
- Relenza web site GlaxoSmithKline
Zanamivir Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD